NewsStocksNuScale Power (SMR) Shares Fall 83% From Peak as Revenue Collapses and Dilution Threatens Shareholders

NuScale Power (SMR) Shares Fall 83% From Peak as Revenue Collapses and Dilution Threatens Shareholders

Author: Blockonomi·

Key Takeaways

  • NuScale reported quarterly revenue of only $0.07 million, a 99.1% decline year-over-year that fell far short of the $8.80 million analysts expected.
  • The company has announced a $750 million equity offering, raising dilution concerns as it burns cash and projects a full-year loss of $0.64 per share.
  • Long-time institutional backer Fluor has completely liquidated its NuScale holdings, sending a negative signal to the market.
  • Insider selling totaled 68,651 shares over the trailing three months, including disposals by the CFO and COO attributed to tax obligations from equity vesting.
  • Analyst consensus is Hold with a mean price target of $13.50, and of 17 analysts covering the stock, nine recommend Hold and three suggest Sell.
NuScale Power (SMR) Shares Fall 83% From Peak as Revenue Collapses and Dilution Threatens Shareholders

Shares of NuScale Power (SMR) are trading around $9.70, an approximately 83% decline from the stock's 52-week high of $57.42. The company still carries a market capitalization near $4 billion—a substantial valuation for a business generating virtually no revenue.

NuScale is one of the most prominent players in the emerging small modular reactor sector. Its uprated 77-megawatt VOYGR module design became the first SMR technology to receive U.S. Nuclear Regulatory Commission design certification approval in 2023, positioning the company at the front of a field that has attracted growing interest as data-center operators and utilities explore nuclear power to meet rising electricity demand. That backdrop helped drive the stock's run-up to its 52-week high, and the subsequent decline reflects the gap between that promise and the company's current financial results.

In its most recent quarterly report, NuScale recorded just $0.07 million in revenue, a 99.1% drop compared with the prior-year period and far below analyst expectations of $8.80 million. The company did, however, meet consensus earnings-per-share forecasts, posting a loss of $0.13 per share.

The revenue shortfall is not the only issue weighing on the market. NuScale has yet to secure a confirmed initial sale of its small modular reactor platform, leaving its commercial viability in question. The company's path to a first deployment has already seen setbacks: its flagship Carbon Free Power Project with Utah Associated Municipal Power Systems was terminated in late 2023 after insufficient subscriber commitments, redirecting attention to newer prospects such as the TVA-linked effort. Investor anxiety has also been heightened by the exit of Fluor, a significant institutional stakeholder with a long history of support, which has completely liquidated its holdings. The departure of such a prominent backer sent a negative signal to the market.

Mounting Cash Concerns and Shareholder Dilution

NuScale continues to deplete its cash reserves without an evident path to near-term profitability. Wall Street projects full-year earnings per share of -$0.64 for the current fiscal period.

Compounding these challenges, NuScale has announced plans for a $750 million equity offering, raising the prospect of significant dilution for existing shareholders. The company also executed a $506 million milestone payment to ENTRA1 Energy in connection with a prospective SMR project involving the Tennessee Valley Authority (TVA).

Executive transactions have drawn scrutiny as well. Chief Financial Officer Robert Hamady sold approximately 30,000 shares in late August at $9.39 each, and Chief Operating Officer Carl Fisher disposed of more than 18,000 shares in early August. Both transactions were attributed to tax liabilities arising from equity compensation vesting, but aggregate insider selling reached 68,651 shares over the trailing three months.

Institutional activity presents a more nuanced picture. Vanguard expanded its position by 40.5%, Van Eck Associates nearly doubled its stake, and Morgan Stanley also increased its holdings. Collectively, institutional and hedge fund investors control 78.37% of outstanding shares.

Wall Street's Perspective

Analyst sentiment remains divided. The prevailing consensus is "Hold," with a mean price target of $13.50—substantially above current trading levels.

Bank of America assigns a "Neutral" rating with a $12 price target. Truist also rates the stock "Hold" with a $10 target, while Goldman Sachs has set a $9 objective. On the bullish side, B. Riley Financial and Canaccord Genuity maintain "Buy" ratings, though both recently lowered their targets—B. Riley from $19 to $15 and Canaccord from $25 to $15.

Of the 17 analysts covering the stock, one rates it Strong Buy, four assign Buy, nine recommend Hold, and three suggest Sell.

The stock has a beta of 2.30, indicating heightened volatility in either direction. Its 50-day moving average stands at $9.12, and its 200-day moving average at $10.80. NuScale's 52-week range spans a low of $7.21 to a high of $57.42.